Qualitative Study About Psychedelics Using in Psychiatric Disorders (PSYCHEQUALI)

Toulouse University Hospital

Status: Not yet enrolling

Conditions: Psychiatric Disorder

Treatments: Diagnostic Test: Interview

Study type: Observational

Funder types: Other

Identifiers

NCT06014164

2023-A01575-40 (Other Identifier)

RC31/23/0396

Details and patient eligibility

About

This study is set up to better understand the current use of psychedelics in France in the general population. The present focus on individuals who have used any type of psychedelic drug in order to suppress or alleviate a psychiatric symptom in the context of a diagnosed pathology. The data are collected during a semi-structured interview and then studied in a thematic analysis.

Enrollment: 25 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients diagnosed with a psychiatric disorder by a psychiatrist or general practitioner
• Patients used psychedelic or related substances in order to treat psychiatric symptoms
• Patients have given their oral non-opposition
• Patients affiliated to a social security scheme

Exclusion criteria

• Patients who don't speak or understand French
• Patients under protection, guardianship or curators

Trial design

25 participants in 1 patient group

Patients using psychedelic substances

Description:

Adult patients self-administering psychedelic substances in psychiatric disorders

Treatment:

Diagnostic Test: Interview